5 things to know before the stock market opens Thursday

5 things to know before the stock market opens Thursday


British Prime Minister Boris Johnson listens to Qatar’s Emir Sheikh Tamim bin Hamad al Thani (not pictured) at the start of their meeting at 10 Downing Street, in London, Britain May 24, 2022. 

Matt Dunham | Reuters

Here are the most important news items that investors need to start their trading day:

1. The end of Boris Johnson

Boris Johnson’s political crisis has reached its climax. He announced that he would soon step down as U.K. prime minister as he resigned as the head of the Conservative Party. Johnson’s tenure has been rocked by scandal after scandal, and dozens of officials in his government have quit to protest his leadership. The pound rose against the dollar and the U.K.’s FTSE 100 stock index jumped as news reports about Johnson’s fate swirled. Johnson’s departure could also have major geopolitical ramifications. He has been a stalwart supporter of Ukraine in its war against Russia and a major partner of the U.S. and other Western powers as they seek to check Vladimir Putin’s influence on the world stage.

2. Momentum for stocks?

Traders work on the floor of the New York Stock Exchange.

NYSE

U.S. stock futures pointed to a higher open Thursday morning following three straight days of gains from the S&P 500. Investors are eager for signs of stability after the worst first half for stocks in more than five decades, which plunged the S&P 500 into a bear market. It’s still not clear whether stocks will break out in a meaningful way anytime soon, however, as price increases continue to take a toll on consumers and the Federal Reserve plans to keep up aggressive rate hikes to beat back inflation.

3. The Fed’s thinking

U.S. Federal Reserve Board Chairman Jerome Powell takes questions from reporters after the Federal Reserve raised its target interest rate by three-quarters of a percentage point to stem a disruptive surge in inflation, during a news conference following a two-day meeting of the Federal Open Market Committee (FOMC) in Washington, June 15, 2022.

Elizabeth Frantz | Reuters

Minutes from the Fed’s June meeting, which were released Wednesday, revealed that the central bank is prepared to use even more restrictive measures to tame surging inflation. They indicated that July’s meeting would bring another rate hike of up to 75 basis points, and acknowledged that the economy could suffer a slowdown. “Participants concurred that the economic outlook warranted moving to a restrictive stance of policy, and they recognized the possibility that an even more restrictive stance could be appropriate if elevated inflation pressures were to persist,” the minutes said. Treasury yields, meanwhile, continued to rise.

4. Samsung sparks chip rally in Asia

People walk past the logo of Samsung Electronics in Seoul on July 7, 2022. South Korea’s Samsung Electronics Co Ltd turned in its best April-June profit since 2018 on Thursday, underpinned by strong sales of memory chips to server customers even as demand from inflation-hit smartphone makers cools.

Jung Yeon-je | Afp | Getty Images

Samsung gave chip stocks a much-sought-after reprieve Thursday when it offered “better than feared” revenue guidance for the second quarter. Shares of the South Korean tech giant rose, prompting a rally in Asian chipmakers. It’s been a rough year for the semiconductor space, as it contends with surging prices for materials and supply chain problems that have been exacerbated by Russia’s war in Ukraine.

5. Pops for a couple Ryan Cohen stocks

A screen displays the logo and trading information for GameStop on the floor of the New York Stock Exchange (NYSE) March 29, 2022.

Brendan McDermid | Reuters

Two companies tied to activist investor Ryan Cohen announced notable developments Wednesday evening. Meme stock GameStop, where Cohen is chairman, said its board approved a 4-for-1 stock split, boosting the video game retailer in off-hours trading. Elsewhere, Bed Bath & Beyond disclosed that interim CEO Sue Gove recently bought 50,000 shares of the troubled home goods retailer, sending the stock higher. Gove took over at Bed Bath during a major executive shuffle last week. Earlier this year, Cohen, who had been pushing for a shake-up as well as a sale of the retailer’s Buybuy Baby chain, struck a deal with the company to put three people from his firm on the board.

– CNBC’s Silvia Amaro, Elliot Smith, Sam Meredith, Jesse Pound, Sarah Min, Jeff Cox and Arjun Kharpal contributed to this report.

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every stock move. Follow the broader market action like a pro on CNBC Pro.



Source

E.l.f. Beauty posts earnings beat, raises full-year guidance
Business

E.l.f. Beauty posts earnings beat, raises full-year guidance

Elf Beauty cosmetics Courtesy: e.l.f Beauty E.l.f. Beauty reported a huge earnings beat Wednesday and raised its guidance for the fiscal year. E.l.f. stock was up as much as 15% in after-hours trading before losing the majority of those gains. Here’s what the company reported for the third fiscal quarter, compared with analyst estimates from […]

Read More
Terrell Owens calls Hall of Fame process ‘broken’ after Belichick, Kraft snubs
Business

Terrell Owens calls Hall of Fame process ‘broken’ after Belichick, Kraft snubs

NFL Hall of Famer Terrell Owens said Wednesday that the recent snubs of New England Patriots owner Robert Kraft and former coach Bill Belichick from the institution show the system is flawed, and someone needs to be held accountable. “It’s just plain dumb” Owens told CNBC Sport in an interview in San Francisco ahead of […]

Read More
Eli Lilly’s GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026
Business

Eli Lilly’s GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026

The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters It’s a tale of two drugmakers in the red-hot obesity drug market.  Both Novo Nordisk and Eli Lilly are grappling with lower prices in the U.S., but their 2026 outlooks are diverging sharply: While Novo is bracing for a sales decline, […]

Read More